Annual Retained Earnings
-$372.40 M
-$18.17 M-5.13%
December 31, 2023
Summary
- As of February 7, 2025, IPHA annual retained earnings is -$372.40 million, with the most recent change of -$18.17 million (-5.13%) on December 31, 2023.
- During the last 3 years, IPHA annual retained earnings has fallen by -$101.24 million (-37.34%).
- IPHA annual retained earnings is now -1950.15% below its all-time high of -$18.16 million, reached on December 31, 2010.
Performance
IPHA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$387.66 M
-$15.26 M-4.10%
June 30, 2024
Summary
- As of February 7, 2025, IPHA quarterly retained earnings is -$387.66 million, with the most recent change of -$15.26 million (-4.10%) on June 30, 2024.
- Over the past year, IPHA quarterly retained earnings has dropped by -$30.56 million (-8.56%).
- IPHA quarterly retained earnings is now -2034.15% below its all-time high of -$18.16 million, reached on December 31, 2010.
Performance
IPHA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
IPHA Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.1% | -8.6% |
| 3 y3 years | -37.3% | -8.6% |
| 5 y5 years | -141.5% | -8.6% |
IPHA Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.8% | at low | -39.5% | at low |
| 5 y | 5-year | -113.6% | at low | -107.6% | at low |
| alltime | all time | -1950.2% | at low | -2034.2% | at low |
Innate Pharma SA Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | -$387.66 M(+4.1%) |
| Dec 2023 | -$372.40 M(+5.1%) | -$372.40 M(+4.3%) |
| Jun 2023 | - | -$357.10 M(+0.8%) |
| Dec 2022 | -$354.23 M(+14.9%) | -$354.23 M(+27.5%) |
| Jun 2022 | - | -$277.80 M(-9.9%) |
| Dec 2021 | -$308.20 M(+13.7%) | -$308.20 M(+6.1%) |
| Jun 2021 | - | -$290.55 M(+7.2%) |
| Dec 2020 | -$271.16 M(+55.5%) | -$271.16 M(+45.2%) |
| Jun 2020 | - | -$186.75 M(+7.1%) |
| Dec 2019 | -$174.38 M(+13.1%) | -$174.38 M(+26.1%) |
| Jun 2019 | - | -$138.34 M(-10.3%) |
| Dec 2018 | -$154.19 M(-15.4%) | -$154.19 M(-11.2%) |
| Jun 2018 | - | -$173.66 M(-4.8%) |
| Dec 2017 | -$182.33 M(+66.5%) | -$182.33 M(+25.5%) |
| Jun 2017 | - | -$145.23 M(+32.6%) |
| Dec 2016 | -$109.52 M(-13.8%) | -$109.52 M(-17.5%) |
| Jun 2016 | - | -$132.82 M(+4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | -$127.08 M(-4.6%) | -$127.08 M(-2.7%) |
| Jun 2015 | - | -$130.67 M(-1.9%) |
| Dec 2014 | -$133.19 M(+7.2%) | -$133.19 M(-1.4%) |
| Jun 2014 | - | -$135.07 M(+8.7%) |
| Dec 2013 | -$124.23 M(+7.9%) | -$124.23 M(+6.6%) |
| Jun 2013 | - | -$116.50 M(+1.2%) |
| Dec 2012 | -$115.15 M(+6.2%) | -$115.15 M(+7.8%) |
| Jun 2012 | - | -$106.84 M(-1.4%) |
| Dec 2011 | -$108.40 M(+496.8%) | -$108.40 M(-8.5%) |
| Jun 2011 | - | -$118.54 M(+552.6%) |
| Dec 2010 | -$18.16 M(-79.9%) | -$18.16 M(-76.4%) |
| Jun 2010 | - | -$76.89 M(-15.0%) |
| Dec 2009 | -$90.41 M(+33.1%) | -$90.41 M |
| Dec 2008 | -$67.92 M(+35.0%) | - |
| Dec 2007 | -$50.30 M(+45.8%) | - |
| Dec 2006 | -$34.49 M(+47.4%) | - |
| Dec 2005 | -$23.40 M | - |
FAQ
- What is Innate Pharma SA annual retained earnings?
- What is the all time high annual retained earnings for Innate Pharma SA?
- What is Innate Pharma SA annual retained earnings year-on-year change?
- What is Innate Pharma SA quarterly retained earnings?
- What is the all time high quarterly retained earnings for Innate Pharma SA?
- What is Innate Pharma SA quarterly retained earnings year-on-year change?
What is Innate Pharma SA annual retained earnings?
The current annual retained earnings of IPHA is -$372.40 M
What is the all time high annual retained earnings for Innate Pharma SA?
Innate Pharma SA all-time high annual retained earnings is -$18.16 M
What is Innate Pharma SA annual retained earnings year-on-year change?
Over the past year, IPHA annual retained earnings has changed by -$18.17 M (-5.13%)
What is Innate Pharma SA quarterly retained earnings?
The current quarterly retained earnings of IPHA is -$387.66 M
What is the all time high quarterly retained earnings for Innate Pharma SA?
Innate Pharma SA all-time high quarterly retained earnings is -$18.16 M
What is Innate Pharma SA quarterly retained earnings year-on-year change?
Over the past year, IPHA quarterly retained earnings has changed by -$30.56 M (-8.56%)